Baillie Gifford & CO Schrodinger, Inc. Transaction History
Baillie Gifford & CO
- $128 Billion
- Q3 2025
A detailed history of Baillie Gifford & CO transactions in Schrodinger, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 974,795 shares of SDGR stock, worth $19.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
974,795
              Previous 985,660
              
        
           1.1%
        
      
          
        Holding current value
$19.9 Million
            Previous $19.8 Million
            
        
           1.4%
        
      
          
        % of portfolio
0.02%
            Previous 0.02%
          
        Shares
	  17 transactions
	
  Others Institutions Holding SDGR
# of Institutions
266Shares Held
72.6MCall Options Held
1.66MPut Options Held
263K- 
    
      Black Rock Inc. New York, NY8.52MShares$174 Million0.0% of portfolio
- 
    
      Bill Gates Bill & Melinda Gates Foundation Trust | Kirkland, Wa6.98MShares$143 Million0.29% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA6.62MShares$135 Million0.0% of portfolio
- 
    
      Rubric Capital Management LP New York, NY5MShares$102 Million2.32% of portfolio
- 
    
      Sumitomo Mitsui Trust Holdings, Inc.4.55MShares$93.2 Million0.05% of portfolio
About Schrodinger, Inc.
- Ticker SDGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 62,028,400
- Market Cap $1.27B
- Description
- Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...